Literature DB >> 16642467

Radon, secondhand smoke, glutathione-S-transferase M1 and lung cancer among women.

Matthew R Bonner1, William P Bennett, Wenying Xiong, Qing Lan, Ross C Brownson, Curtis C Harris, R William Field, Jay H Lubin, Michael C R Alavanja.   

Abstract

Tobacco smoke and ionizing radiation induce oxidative stress by transmitting or generating reactive oxygen species (ROS). We hypothesized that glutathione-S-transferase M1 (GSTM1) null homozygotes would have decreased ability to neutralize ROS that might increase their susceptibility to lung cancer. A case-only design was used with lung cancer cases pooled from 3 previously completed case-control studies using archival tissue samples from 270 lung cancer cases to genotype GSTM1. Radon concentrations were measured with long-term alpha-track radon detectors. Secondhand smoke (SHS) was measured with questionnaires and interviews. Unconditional logistic regression was used to calculate the interaction odds ratios (OR) and 95% confidence intervals (95% CI). Radon concentrations >121 Bq m(-3) were associated with a >3-fold interaction OR (OR = 3.41; 95% CI = 1.10, 10.61) for GSTM1 null homozygotes compared to GSTM1 carriers; the linear trend was significant (p trend = 0.03). The SHS and GSTM1 interaction OR was also elevated (OR = 2.28; 95% CI = 1.15-4.51) among never-smokers. This may be the first study to provide evidence of a GSTM1 and radon interaction in risk of lung cancer. Additionally, these findings support the hypothesis that radon and SHS promote neoplasia through shared elements of a common pathway.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16642467     DOI: 10.1002/ijc.22002

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  7 in total

1.  Lung cancer incidence in never smokers.

Authors:  Heather A Wakelee; Ellen T Chang; Scarlett L Gomez; Theresa H Keegan; Diane Feskanich; Christina A Clarke; Lars Holmberg; Lee C Yong; Laurence N Kolonel; Michael K Gould; Dee W West
Journal:  J Clin Oncol       Date:  2007-02-10       Impact factor: 44.544

Review 2.  SEER cancer registry biospecimen research: yesterday and tomorrow.

Authors:  Sean F Altekruse; Gabriel E Rosenfeld; Danielle M Carrick; Emilee J Pressman; Sheri D Schully; Leah E Mechanic; Kathleen A Cronin; Brenda Y Hernandez; Charles F Lynch; Wendy Cozen; Muin J Khoury; Lynne T Penberthy
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-12       Impact factor: 4.254

3.  Genomic Profiling of Lung Adenocarcinoma in Never-Smokers.

Authors:  Siddhartha Devarakonda; Yize Li; Fernanda Martins Rodrigues; Sumithra Sankararaman; Humam Kadara; Chandra Goparaju; Irena Lanc; Kymberlie Pepin; Saiama N Waqar; Daniel Morgensztern; Jeffrey Ward; Ashiq Masood; Robert Fulton; Lucinda Fulton; Michael A Gillette; Shankha Satpathy; Steven A Carr; Ignacio Wistuba; Harvey Pass; Richard K Wilson; Li Ding; Ramaswamy Govindan
Journal:  J Clin Oncol       Date:  2021-09-30       Impact factor: 44.544

Review 4.  Lung cancer in never smokers: molecular profiles and therapeutic implications.

Authors:  Charles M Rudin; Erika Avila-Tang; Curtis C Harris; James G Herman; Fred R Hirsch; William Pao; Ann G Schwartz; Kirsi H Vahakangas; Jonathan M Samet
Journal:  Clin Cancer Res       Date:  2009-09-15       Impact factor: 12.531

Review 5.  Gene mutation discovery research of non-smoking lung cancer patients due to indoor radon exposure.

Authors:  Jung Ran Choi; Seong Yong Park; O Kyu Noh; Young Wha Koh; Dae Ryong Kang
Journal:  Ann Occup Environ Med       Date:  2016-03-16

6.  Meta-Analysis and Systematic Review in Environmental Tobacco Smoke Risk of Female Lung Cancer by Research Type.

Authors:  Xue Ni; Ning Xu; Qiang Wang
Journal:  Int J Environ Res Public Health       Date:  2018-06-27       Impact factor: 3.390

7.  Radon Exposure-induced Genetic Variations in Lung Cancers among Never Smokers.

Authors:  Jung Ran Choi; Sang Baek Koh; Hye Ryun Kim; Hyojin Lee; Dae Ryong Kang
Journal:  J Korean Med Sci       Date:  2018-06-20       Impact factor: 2.153

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.